Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Mar 22, 2023 8:27pm
RE:RE:RE:Love the markets like this ...
Yes, the cash flow is great but I am also very interested in the return on shareholder equity. Most of the cash flow is a result of adding back depreciation; however, that depreciation is real and
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Mar 22, 2023 3:32pm
RE:RE:Love the markets like this ...
Re: operations... in the first nine months of 2022, we had $48M of operational cash flow before working capital adjustments. If you exclude the $6M settlement, that's $42M of operational cash flow
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Mar 22, 2023 11:26am
RE:Love the markets like this ...
I agree with you regarding opportunities and the need to execute. Management needs to provide a very meaningful update tomorrow in order to demonstate the path to value creation at Knight. The
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Mar 19, 2023 1:06pm
RE:Love the markets like this ...
Mugsy boy, GUD colapsed below $5 and shortseller shark may finaly decide what it is realy worth. As GUD kept buying back shares the market cap of GUD did the opposite going going lower. The all point
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 18, 2023 10:12am
Love the markets like this ...
It is in times like this, when panic fills the air (banking concerns), that I am most interested in what GUD might do strategically. No big risk, just a few add-ons. We also have interest rates
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Mar 18, 2023 9:57am
RE:RE:GUD AND PATIENCE
Well said. This team ran the business for 19 years the first time and they never once offered a dividend. That simply isn't in their DNA. Are they looking at acquisitions of depressed assets
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 16, 2023 7:30am
New Press Release - Notice of Knight Therapeutics' Fourth Quarter and Year End 2022 Results Conference Call
MONTREAL, March 16, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2022 financial results on Thursday, March 23, 2023 prior to market opening. Following the...
read article.
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Mar 14, 2023 10:35am
RE:GUD AND PATIENCE
You are getting compensated for waiting as buybacks are tax free dividends. You could sell the equivalent number of shares. We're average buybacks this year of 4-5%. In theory, if the company was
...more
(1)
•••
Stockoman1
X
View Profile
View Bullboard History
Post by
Stockoman1
on Mar 14, 2023 6:28am
GUD AND PATIENCE
Not even a dividend while we wait and wait and wait and wait !
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Mar 12, 2023 12:21pm
RE:RE:More Buybacks
My math could be wrong here as I was thinking about 2019 when it was resolved but it closed in 2020. So might be another year until March 2024
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Mar 11, 2023 8:53am
RE:More Buybacks
Love to see it. Also, looking back on past press releases, The GUD/Medison deal to unwind partnership closed on March 16th, 2020. From my understanding they had a four year period to sell their
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Mar 11, 2023 2:00am
More Buybacks
Not as fast of a pace as a while back... but 436 000 shares in February.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Comment by
GoldenInvestor
on Mar 01, 2023 8:10am
RE:Exciting times as Rare diseases being profiled on CNBC +
- market for RARE DISEASES Expected to DOUBLE to MORE than $68 BILLION by 2027!
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Feb 28, 2023 2:55pm
Exciting times as Rare diseases being profiled on CNBC +
7000 rare diseases affecting 300 million people worldwide Rare diseases descriptors - affects typically fewer than 200k people Market values at $29 B !!!! Expected to double to
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results